Durex nixes nonoxynol-9
This article was originally published in The Tan Sheet
Executive Summary
Condom marketer will discontinue the use of the spermicide nonoxynol-9 in manufacturing its Durex condom line due to an anticipated "material reduction in demand for spermicidally lubricated condoms," SSL International announces recently. The decision follows a report by the World Health Organization "which questioned the level of additional protection provided by such condoms when compared to non-spermicidally lubricated condoms," London-based company says. The WHO's June 2002 report also recommended evaluating the safety of spermicides following research that showed their use may increase the risk of STD transmission (1"The Tan Sheet" July 8, 2002, p. 17)...
You may also be interested in...
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.